Metis Techbio inks up to $1.1bn drug delivery deal with Eli Lilly

Metis Techbio has entered a strategic collaboration with Eli Lilly worth up to $1.1 billion for drug delivery technology, according to Reuters.

Detected & updated continuously · Source: Nebula

Story subjects

Eli Lilly & Co.Metis Techbio

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula